In the last trading session, 2.06 million shares of the Phio Pharmaceuticals Corp (NASDAQ:PHIO) were traded, and its beta was 1.51. Most recently the company’s share price was $2.77, and it changed around -$0.14 or -4.81% from the last close, which brings the market valuation of the company to $11.54M. PHIO currently trades at a discount to its 52-week high of $10.35, offering almost -273.65% off that amount. The share price’s 52-week low was $1.53, which indicates that the current value has risen by an impressive 44.77% since then. We note from Phio Pharmaceuticals Corp’s average daily trading volume that its 10-day average is 35.15 million shares, with the 3-month average coming to 5.98 million.
Phio Pharmaceuticals Corp stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 0 recommended PHIO as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight.
Phio Pharmaceuticals Corp (NASDAQ:PHIO) trade information
Instantly PHIO has showed a red trend with a performance of -4.81% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 9.79 on recent trading dayincreased the stock’s daily price by 71.71%. The company’s shares are currently up 53.89% year-to-date, but still up 63.91% over the last five days. On the other hand, Phio Pharmaceuticals Corp (NASDAQ:PHIO) is -2.46% down in the 30-day period. We can see from the shorts that 51491.0 shares have been sold at a short interest cover period of 0.5 day(s).
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 62.38%.
PHIO Dividends
Phio Pharmaceuticals Corp’s next quarterly earnings report is expected to be released in February.
Phio Pharmaceuticals Corp (NASDAQ:PHIO)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 4.81% of Phio Pharmaceuticals Corp shares, and 3.02% of them are in the hands of institutional investors. The stock currently has a share float of 3.17%.
Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund were the top two Mutual Funds as of Nov 30, 2024 . The former held 4.29 shares worth $11883.0, making up 0.29% of all outstanding shares. On the other hand, Vanguard Extended Market Index Fund held roughly 2.71 shares worth around $7498.0, which represents about 0.18% of the total shares outstanding.
